Health Condition 1: N602- Fibroadenosis of breast
Conditions
Interventions
Intervention1: KETAMINE - DEXMEDETOMIDINE: TO STUDY THE EFFICACY OF KETAMINE - DEXMEDETOMIDINE AS SEDATION IN CASES OF FIBROADENOMA KETAMINE AT THE DOSE OF 1-2mg/kg AND DEXMEDETOMIDINE AT THE DOSE OF
Sponsors
Gulbarga Institute of Medical Sciences
Eligibility
Inclusion criteria
Inclusion criteria: adult patient aged from 18 yrs to 60 yrs posted for surgical excision of fibroadenoma and belongs to ASA-1 and ASA-2 those who have given consent
Exclusion criteria
Exclusion criteria: adult aged more than 60 years and anticipated difficult airway and those who have allergy to drugs pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| to determine the efficacy between ketamine-propofol and dexmedetomidine- ketamine on adequate sedation using Ramsay sedation scaleTimepoint: Ketamine- Propofol is administered during the start of the surgery and using Ramsay sedation scale sedation score is given for every 5mins until the surgery is completed . For another group patient receiving Ketamine-Dexmedetomidine sedation score is given after this drug administration using Ramsay sedation scale from the start of the surgery to every 5 mins until the surgery is completed | — |
Secondary
| Measure | Time frame |
|---|---|
| recovery time from sedation in cases posted for surgical excision of breast fibroadenomaTimepoint: recovery time is assessed once the surgery is completed using modified Aldrete score is given every 5 mins upto 30 mins | — |
Countries
India
Contacts
Public ContactDr Keerthana R
Gulbarga Institute of Medical Sciences
Outcome results
None listed